Neutral
Top Cytokinetics Insiders Quietly Cash In On Their Shares
Cytokinetics (CYTK) insiders, including the President & CEO and EVP & CCO, recently sold shares totaling approximately $982,132. These sales took plac...
CYTK
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (1)
Latest CYTK News
Neutral
Bearish
Insider Sell: Andrew Callos Sells 7,449 Shares of Cytokinetics I
Andrew Callos, Executive Vice President, Chief Commercial Officer at Cytokinetics Inc (CYTK), sold 7,449 shares of the company on April 15, 2026. This...
Research CYTK on:
Ad Space